A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: This study will investigate whether the combination of PF-05212384 plus Irinotecan improves progression free survival in patients with KRAS and NRAS wild type metastatic colorectal cancer when compared with the combination of cetuximab plus Irinotecan. A Japanese Lead in Cohort will assess the safety of the combination of PF-05212384 + irinotecan in patients enrolled at Japanese sites.
DISEASE(S): Metastatic Colorectal Cancer,Colon Cancer,N-ras Gene Mutation,Colorectal Cancer,K-ras Gene Mutation,Colorectal Neoplasms
PROVIDER: 2150287 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA